NCT04156230View on ClinicalTrials.gov

Diagnostic Validity of [18F]GP1 PET for Diagnosing Acute Deep Vein Thrombosis

PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

January 13, 2020

Primary Completion Date

August 13, 2025

Study Completion Date

August 13, 2025

Conditions
Venous Thrombosis
Interventions
DRUG

[18F]GP1 positron emission tomography/computed tomography

A radioactive dose of 250 MBq of the study drug with a total quantity of ≤ 10 µg will be administered as slow intravenous bolus injection over up to 60 seconds. PET/CT examinations will be performed at 120 ± 15 min after the administration of \[18F\]GP1.

Trial Locations (1)

05505

Asan Medical Center, Seoul

All Listed Sponsors
lead

Dae Hyuk Moon

OTHER

NCT04156230 - Diagnostic Validity of [18F]GP1 PET for Diagnosing Acute Deep Vein Thrombosis | Biotech Hunter | Biotech Hunter